R&D News
Most Popular R&D Story
Pfizer: $800M in cuts to hit 4Q
Pfizer's pharma chief gave an update on the drugmaker's restructuring, and the news is that the company has slashed $1.2 billion off 2006 cost levels Read more...
Latest Headlines
- February 4, 2010
- February 4, 2010
- November 19, 2009
- April 15, 2009
- February 19, 2009
- January 21, 2009
- October 31, 2008
- October 22, 2008
- October 1, 2008
- October 1, 2008
- September 23, 2008
- April 9, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
